[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2013 [#4]

Announcement Date
24-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 60.53%
YoY- -10.55%
Quarter Report
View:
Show?
Cumulative Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 1,495,830 993,744 468,672 1,946,639 1,378,779 937,972 500,339 107.39%
PBT 87,726 62,781 38,159 92,997 59,990 46,529 36,924 77.95%
Tax -30,122 -20,178 -11,513 -36,236 -24,496 -15,205 -11,771 86.98%
NP 57,604 42,603 26,646 56,761 35,494 31,324 25,153 73.65%
-
NP to SH 57,147 42,192 26,217 55,200 34,387 30,636 24,771 74.50%
-
Tax Rate 34.34% 32.14% 30.17% 38.96% 40.83% 32.68% 31.88% -
Total Cost 1,438,226 951,141 442,026 1,889,878 1,343,285 906,648 475,186 109.09%
-
Net Worth 507,513 502,162 515,022 486,754 473,857 481,681 484,829 3.09%
Dividend
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Div 41,429 20,707 10,352 41,477 25,427 17,661 8,825 180.10%
Div Payout % 72.50% 49.08% 39.49% 75.14% 73.95% 57.65% 35.63% -
Equity
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Net Worth 507,513 502,162 515,022 486,754 473,857 481,681 484,829 3.09%
NOSH 258,935 258,846 258,805 258,911 258,938 258,968 117,676 69.09%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 3.85% 4.29% 5.69% 2.92% 2.57% 3.34% 5.03% -
ROE 11.26% 8.40% 5.09% 11.34% 7.26% 6.36% 5.11% -
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
RPS 577.69 383.91 181.09 751.85 532.47 362.20 425.18 22.64%
EPS 22.07 16.30 10.13 21.32 13.28 11.83 21.05 3.20%
DPS 16.00 8.00 4.00 16.02 9.82 6.82 7.50 65.64%
NAPS 1.96 1.94 1.99 1.88 1.83 1.86 4.12 -39.03%
Adjusted Per Share Value based on latest NOSH - 258,868
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
RPS 103.79 68.95 32.52 135.07 95.67 65.08 34.72 107.37%
EPS 3.97 2.93 1.82 3.83 2.39 2.13 1.72 74.56%
DPS 2.87 1.44 0.72 2.88 1.76 1.23 0.61 180.51%
NAPS 0.3521 0.3484 0.3573 0.3377 0.3288 0.3342 0.3364 3.08%
Price Multiplier on Financial Quarter End Date
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Date 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 -
Price 4.63 4.61 4.46 4.45 4.82 4.49 8.26 -
P/RPS 0.80 1.20 2.46 0.59 0.91 1.24 1.94 -44.56%
P/EPS 20.98 28.28 44.03 20.87 36.30 37.95 39.24 -34.10%
EY 4.77 3.54 2.27 4.79 2.76 2.63 2.55 51.75%
DY 3.46 1.74 0.90 3.60 2.04 1.52 0.91 143.40%
P/NAPS 2.36 2.38 2.24 2.37 2.63 2.41 2.00 11.65%
Price Multiplier on Announcement Date
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Date 21/11/14 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 -
Price 4.45 4.62 4.70 4.29 4.72 4.66 9.26 -
P/RPS 0.77 1.20 2.60 0.57 0.89 1.29 2.18 -50.00%
P/EPS 20.16 28.34 46.40 20.12 35.54 39.39 43.99 -40.53%
EY 4.96 3.53 2.16 4.97 2.81 2.54 2.27 68.30%
DY 3.60 1.73 0.85 3.73 2.08 1.46 0.81 170.07%
P/NAPS 2.27 2.38 2.36 2.28 2.58 2.51 2.25 0.59%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment